drugset
drugset / Trial / NCT03445338

To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers

NCT03445338 ↗

Phase 1 Completed 18 enrolled Sun Pharma Advanced Research Company Limited
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is an open-label, multiple-dose study to evaluate the plasma and CSF pharmacokinetics of K0706 in healthy adult male subjects.

Timeline

Start
2018-04-15
Primary completion
2019-12-06
Completion
2019-12-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Vodobatinib Small molecule — —

Indications

No indication recorded.